The prevalence and risk factors of epiretinal membranes: the Melbourne Collaborative Cohort Study.
about
Epiretinal membrane: optical coherence tomography-based diagnosis and classificationSpectral domain optical coherence tomography characterization of pediatric epiretinal membranesInfluence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials.The Association between Smoking and Epiretinal Membrane.INTRAOPERATIVE SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY IMAGING AFTER INTERNAL LIMITING MEMBRANE PEELING IN IDIOPATHIC EPIRETINAL MEMBRANE WITH CONNECTING STRANDSThe Prevalence and Distribution of Vitreoretinal Interface Abnormalities among Urban Community Population in China.Deferral of surgery for epiretinal membranes: Is it safe? Results of a randomised controlled trial.Statin medication in patients with epiretinal membrane is associated with low intravitreal EPO, TGF-beta-1, and VEGF levelsEpiretinal Membrane: Prevalence and Risk Factors from the Korea National Health and Nutrition Examination Survey, 2008 through 2012.Macular assessment of preoperative optical coherence tomography in ageing Chinese undergoing routine cataract surgery.Recurrence rate and need for reoperation after surgery with or without internal limiting membrane removal for the treatment of the epiretinal membrane.Intraretinal changes in the presence of epiretinal traction.Changes in choroidal thickness after vitrectomy for epiretinal membrane combined with vitreomacular traction.Associations between preoperative OCT parameters and visual outcome 3 months postoperatively in patients undergoing vitrectomy for idiopathic epiretinal membrane.Surgical Outcomes of Idiopathic Epiretinal Membrane: the Gülhane Experience.Ten-year cumulative incidence of epiretinal membranes assessed on fundus photographs. The Beijing Eye Study 2001/2011.
P2860
Q26751383-C12F7457-2F3A-4F93-92BA-D33FAA896F57Q33790716-227A9C50-A081-4C77-8BFB-1B296C34CEFCQ35590569-36315EE9-1DA8-420B-BC19-B730309DE6E3Q36206534-DC313DEA-32EB-42CD-ABB0-98B48A3BD9E2Q36315010-5FA0FE66-7425-47D2-A8D1-EC21114A7624Q36360444-4E4E090C-FBD8-4D60-A614-CE60B3BC5A12Q40996037-D319D94C-9292-48D2-8892-B0249C888308Q42755143-61889213-0F8B-4A99-A9CC-F0F51479F867Q47129589-388E7428-CB36-4842-AB5F-99CD2E14E701Q51760039-56D944E2-5DE3-4651-8EAF-DA181F1A86DCQ51773420-B06A4500-A595-494C-80AA-FF76F399A8F3Q53079866-175F1339-416A-4AB6-9674-B800B80D7C07Q53091190-C2EAC3B5-8B32-4C1F-A563-30490C5F4A62Q53622499-79EC3FEC-ACE9-403E-ABF3-E4709C8A45BDQ55090165-4F4E9737-A786-4C4B-9C82-DB0BD49D3581Q55266614-C71F8926-4779-4D96-8C4C-2BA680FF5801
P2860
The prevalence and risk factors of epiretinal membranes: the Melbourne Collaborative Cohort Study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The prevalence and risk factor ...... ne Collaborative Cohort Study.
@en
type
label
The prevalence and risk factor ...... ne Collaborative Cohort Study.
@en
prefLabel
The prevalence and risk factor ...... ne Collaborative Cohort Study.
@en
P2093
P50
P1433
P1476
The prevalence and risk factor ...... ne Collaborative Cohort Study.
@en
P2093
Elaine W-T Chong
Galina Makeyeva
Khin Z Aung
Liubov D Robman
P304
P356
10.1097/IAE.0B013E3182733F25
P50
P577
2013-05-01T00:00:00Z